Impact of extended to 1-year antithrombotic prophylaxis on pulmonary pressure evolution and on chronic thromboembolic pulmonary hypertension development after acute pulmonary embolism event;Wpływ przedłużonej do roku profilaktyki przeciwzakrzepowej na zachowanie sie ciśnienia płucnego i na możliwość rozwiniecia sie przewlekłego zakrzepowo-zatorowego nadciśnienia płucnego po incydencie ostrej zatorowości płucnej

Polski Przeglad Kardiologiczny

Volumn 7, Issue 5, 2005, Pages 399-403

  Romaszkiewicz, Renata ^a   Lewczuk, Jerzy ^a   Piszko, Piotr ^a   Wrabec, Krzysztof ^a  

^a Szpitala Specjalistycznego ^*  (Poland)

Author keywords

1 year anticoagulation; Chronic thromboembolic pulmonary hypertension; Pulmonary embolism; Pulmonary pressure

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULATION; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG PRESSURE; MALE; PULMONARY HYPERTENSION; THROMBOEMBOLISM;

EID: 28244490553     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dalen I.E., Banas J.S. Jr, Broks H.L. i wsp.: Resolution rate of acute pulmonary embolism in man: an angiographic study. N. Engl. J. Med., 1969, 280, 1194-1199.
2. Ribeiro A., Lindmarker P., Johnsson H. i wsp.: Pulmonary embolism. One-year follow up with echocardiography doppler and five year survival. Circulation, 1999, 99, 1325-1330.
3. Ciurzyński M., Liszewska-Pfeifer D., Jankowski K.: Rokowanie po przebytej ostrej zatorowości płucnei. Kardiol. Pol., 2004, 60, 510-513.
4. Agnelli G., Prandoni P., Becattini C. i wsp.: Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann. Intern. Med., 2003, 139, 19-25.
5. Chemla D., Castelan V., Herve P., Brimioulle S.: Haemodynamic evaluation of pulmonary hypertension. Eur. Respir. J., 2002, 20, 1314-1331.
6. Kasper W., Geibel A., Tiede N. i wsp.: Distinguishing between acute and subacute masssive pulmonary embolism by conventional and doppler echocardiography. Br. Heart J., 1993, 70, 352-356.
7. Berger M., Haimowitz A., van Tosh A. i wsp.: Quantitaive assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol., 1985, 6, 359-365.
8. Brecker S.J., Gibbs J.S., Fox K.M. i wsp.: Comparison of doppler derived hemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br. Heart J., 1994, 72, 384-389.
9. Agnelli A., Prandoni P., Santamaria M.G. i wsp.: Three months versus one year of oral anticoagulant therapy for idiopatic deep venous thrombosis. N. Engl. J. Med., 2001, 345, 165-169.
10. Ridker P.M., Goldhaber S.Z., Danielson E. i wsp.: Long term, low intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N. Engl. J. Med., 2003, 348, 1425-1434.
11. Kearon C., Ginsberg J.S., Kovacs M.J. i wsp.: Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N. Engl. J. Med., 2003, 349, 631-639.
12. Egermayer P., Peacock A.J.: Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitation of the embolic hypothesis. Eur. Respir. J., 2000, 15, 440-446.
13. Tow D.E., Wagner H.N. Jr: Recovery of pulmonary artery blood flow in patients with pulmonary embolism. N. Engl. J. Med., 1967, 276, 1053-1059.
14. Riedel M.: Indications for pulmonary endarterectomy. J. Thorac. Cardiovasc. Surg., 2004, 126, 1227-1228 (letter).